---
name: ees-shadow-monitor-state-2026-06-23
description: "EES v2 Phase 3 shadow monitor — current state, observation gates, and governance conclusion as of 2026-06-23"
metadata: 
  node_type: memory
  type: project
  originSessionId: f3567a5c-fdf8-4963-9f3c-a55b32f3f06a
---

EES diagnostic chain closed at design-only (2026-06-23). No production action authorized.

**Commit chain:**
- `e80c3ff2` — EES forward validation: PASS diagnostic signal observed
- `fb52071f` — Attribution: Phase 3 CT_PRIMARY_COMPLETION left-tail avoidance
- `c35fc1ba` — Shadow monitor spec
- `60876b11` — Shadow monitor implementation (landed on main directly)
- `376d9e9d` — Settled-row immutability hardening
- `96733236` — Left-tail guardrail design memo

**Finding:** EES v2 Phase 3 signal = CT_PRIMARY_COMPLETION left-tail avoidance. Q1 low-score names return -3.47% at 5d / -6.80% at 20d. Q2–Q5 nearly indistinguishable. Signal is a risk brake, not positive alpha.

**Governance conclusion:** No production action authorized. Only active path is prospective shadow observation.

**Shadow monitor gates (both required before any interpretation):**
- Completed 5d observations: ≥ 20 (current: 0)
- Completed 20d observations: ≥ 20 (current: 0)
- Status: `OBSERVATION_WINDOW_INCOMPLETE_NO_INTERPRETATION`

**Daily manual run command (after each promoted snapshot):**
```bash
cd /mnt/c/Projects/biotech_screener/biotech-screener
python3 scripts/research/ees_v2_phase3_shadow_monitor.py --as-of-date YYYY-MM-DD
```

Ledger: `artifacts/shadow/ees_v2_phase3_shadow_ledger.jsonl` (gitignored, local only)

**Next memo (only after gates met):** `EES_V2_PHASE3_SHADOW_MONITOR_EVALUATION_2026_MM_DD.md`

**Why:** Do not add more EES analysis until forward observations accumulate. Discovery → validation → attribution → design → prospective monitor chain is complete. Next evidence must be forward observation.
